Cisplatin resistant cell lines IGROV1 CR and OV90 CR were established by following the previous report40 (link). Briefly, IGROV1 and OV90 cells were treated with cisplatin for six cycles (4 hours of cisplatin treatment, followed by release to cisplatin free medium for three weeks). In the next cycle, cisplatin treatment was repeated with an increased concentration of cisplatin. After five months of treatment (6 cycles), cisplatin resistant cell lines IGROV1 CR and OV90 CR were obtained. Only early-passage (<10 passages) resistant cell lines were used for the study.
Peo4 cells
PEO4 cells are a type of laboratory cell line commonly used in research. They are derived from human embryonic kidney cells and are known for their ability to express a variety of proteins. PEO4 cells can be utilized in various experimental settings to study cellular processes and functions.
Lab products found in correlation
2 protocols using peo4 cells
Establishment of Cisplatin-Resistant Ovarian Cancer Cell Lines
Validating Transcription Factor Binding
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!